Hypertension Landmark Trials 2015: A European Perspective of the Practicing Clinician

Journal of the American College of Cardiology（2016）

引用 1|浏览4

暂无评分

摘要

![Figure][1] The close of 2015 has seen the publication of 2 landmark trials of pharmacotherapy for hypertension (SPRINT [Systolic Blood Pressure Intervention Trial] and PATHWAY-2 [Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要